Protagonist Therapeutics (PTGX) Q3 2023 Earnings

2NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.73
-0.68
-0.63
-0.58

Details

Expected EPS
-0.7
Actual EPS
-0.58
Surprise EPS
0.12
Surprise Percent
+17.14%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.58 per share for Q3 2023.

0 Comments

Share your thoughts